Orphanet: Clinical trials
x

Search for a clinical trial

* (*) mandatory field

COMET: A phase 3 randomized, multicenter, multinational, double-blinded study comparing the efficacy and safety of repeated biweekly infusions of neoGAA (GZ402666) and alglucosidase alfa in treatment-naïve patients with late onset Pompe disease (AT)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Genzyme corporation
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Klinische Abteilung für Endokrinologie und Stoffwechsel
  • Universitätsklinik für Innere Medizin III
  • Allgemeines Krankenhaus der Stadt Wien
  • Währinger Gürtel 18-20
  • 1097 WIEN
  • AUSTRIA
  • More information
  • Phone  : +43 (0)1 40400 60950
  • Fax  : -
  • Website
Last update: March 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.